BMI View: The gradual economic recovery will support the government's plans within the healthcare
sector; however, political instability poses the greatest risk to our outlook. Kuwait's political backdrop is
complicated by labour and population imbalances, as well as ..."
BMI View: With the recent oil strike representing a harbinger of significant political and economic
turbulence ahead, the stability of its health and pharmaceutical sectors will depend on Kuwait's integration
with neighbouring Gulf states and international partners. ..."
BMI View: Despite continued pressure to raise revenues in the face of a protracted oil crisis, increased
strategic cooperation with neighbouring Gulf states and ongoing government investment will provide
Kuwait's pharmaceutical sector with continued growth momentum. ..."
BMI View: Kuwait's pharmaceutical sector will remain insulated from the impact of lower oil prices given
the country's strong fiscal buffers. Risks to our outlook include increasing generic penetration as health
insurance coverage increases.
Headline Expenditure ..."
BMI View: Kuwait's pharmaceutical sector will remain dominated by multinational drugmakers given the
preference for branded products among both prescribers and consumers. Development of the local generics
sector will be stimulated by the implementation of cost-contain ..."
BMI View: While the losses incurred by Yiaco, the largest drug distributor in Kuwait, highlight a
deteriorated near-term operating environment, with markedly lower prices as a result of the ongoing Gulf
Cooperation Council (GCC) medicine price unification process, dru ..."
BMI View: While the persistence of lower oil prices will drive down national budgets and curtail some
investment programmes, we maintain that the healthcare sector's perception as a critical source of
economic diversification away from hydrocarbons in addition to publ ..."
BMI View: The impending dual epidemic of communicable and non-communicable diseases in Kenya will
create business opportunities for multinational drugmakers. Investment into physician and patient
education and therefore addressing one of the barriers to high-quality care in an ..."
BMI View: With some of the largest financial buffers of any GCC member nation, Kuwait is well equipped
to insulate health expenditure from the near-term effects of falling oil prices. Accordingly, drugmakers can
expect high and rising underlying demand for branded pre ..."
BMI View: Notwithstanding a recent escalation in political uncertainty, Kuwait's healthcare sector is
forecast to preserve its trajectory of modest growth throughout the remainder of 2014. Rising sales are
underpinned by an expanding population, whose levels of chroni ..."